Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Evox Therapeutics secures £35.5m in Series B to advance exosome therapeutics Evox Therapeutics, an innovative biotechnology company spun out from Oxford University, has successfully raised £35.5 million in a… bypharmanewsdailySeptember 4, 2018
